Mast Therapeutics merges with Savara; combined company to focus on inhalation therapies
Mast Therapeutics Inc. merged with Savara Inc. and the stockholders of Savara became majority owners of Mast and the operations of the two companies were combined. The new firm will take on the Savara name and be headquartered in Austin, TX.
- Drug Delivery
- Nanotechnology, Chips, etc.
- Acquisition of Private Biotech
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Stock
- Reverse Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com